NEARLYN a quarter of a century has elapsed since the first animal tumours were produced by the application of pure polycyclic aromatic hydrocarbons, and there is still complete ignorance as to the mechanism of local carcinogenic action. It is not known whether it is due to the intact hydrocarbon or to a metabolite, and which of the cell constituents are involved in the process.
. The method of synthesis of 8-hydroxy-3:4-benzpyrene and its methyl ether enabled these pure compounds to be prepared in quantities adequate for biological testing. The results of these tests are now reported, as well as those with 8-methyl-3:4-benzpyrene, which has been synthesised for comparison with the 8-methoxy-compound (Cameron, Cook and Schoental, 1952) .
MATERIAL AND METHODS.
Mice were used for the testing of carcinogenic activity of the pure synthetic 8-hydroxy-, 8-methoxy-and 8-methyl-3:4-benzpyrene. 8-Methoxy-benzpyrene was tested also in rats.
The mice were derived from one pair of CBA strain and were bred locally, as were also the rats which were derived from a commercial stock of albino Wistar rats. The animals were housed in metal cages and received rat cake and tap water ad libitum.
Freshly prepared solutions (the solvents used were redistilled and freed from fluorescent impurities) of the pure crystalline substances (0.5 per cent solution in acetone in the case of 8-hydroxy-3-4-benzpyrene, a saturated solution in acetone or a 0*5 per cent solution in benzene in the case of 8-methoxy-3:4-benzpyrene) were applied twice a week to the intrascapular region of the skin from a capillary pipette, the hair being removed by clipping with scissors. For subcutaneous injections the pure compounds were dissolved in tricaprylin, and the animals were injected in the left flank, care being taken to prevent leakage of the oily solutions. In the majority of cases the injected oily solution formed a defined nodule palpable under the skin and remaining in situ for many weeks or months. The animals were allowed to live as long as possible; but some were killed when moribund, or when the induced tumours attained excessive size. All the animals were examined post mortem, and the tumours and other observed abnormalities confirmed by histological examination. To obtain evidence of the degree of malignancy some of the tumours have been transplanted for several generations into the respective species of animal, and their histological appearance confirmed in the transplants. Fig. 1is a representative example. It shows besides the primary tumour a metastasis which formed a keratinised mass
(1-5 x 1.5 cm.) in the submaxillary gland. Two of these tumours were transplanted into weanling rats, and carried successfully through three generations of transplants, which retained the ability to form keratin. some local irritation; the first tumour appeared after 13 weeks, and 50 per cent of the mice had tumours by about 14 weeks after the injections. All the 18 injected mice developed highly malignant tumours invading the adjacent muscle and other tissues. One of these tumours was carried through 3 generations of transplants, retaining its original structure.
DISCUSSION.
The results here reported present several points of interest.
(a) It is the first time that carcinogenic activity has been demonstrated by the application to the skin of a phenolic metabolite of a carcinogenic hydrocarbon (pure 8-hydroxy-3:4-benzpyrene) in mice. However, the very long induction period (69 weeks for the appearance of the first papilloma and 113 weeks for tumours to develop in 50 per cent of the animals) corresponds with or rather exceeds the survival times of mice in the carcinogenic tests with the other known metabolites. Hence a low degree of carcinogenic activity such as is exhibited by 8-hydroxy-3:4-benzpyrene may not be as isolated a phenomenon as it seems at present.
No tumours were produced by subcutaneous injection of this compound, which in conjunction with the above results makes it obvious that the carcinogenicity of the parent hydrocarbon is considerably reduced (although not completely abolished) by its metabolic transformation into a phenolic derivative. Of the other benzpyrenols so far tested the 4'- (Cook and de Worms, 1937; Shear, 1939) , 2-(Dunlap and Warren, 1941) and 5-(Shear and Leiter, 1940) compounds were inactive, while the 6-isomer produced tumours in 2 out of 40 mice when injected subcutaneously (Dunlap and Warren, 1941) .
(b) Of particular interest is the finding that 8-methoxy-3:4-benzpyrene exhibits a sarcomatogenic and carcinogenic activity of the highest order in both the species tested, mice and rats. While rats are known to develop sarcomata readily on subcutaneous injections of carcinogens, not many skin tumours have been produced in rats by the application of tar or pure carcinogenic hydrocarbons. Berenblum (1949) summarized the relevant literature when he reported on the carcinogenicity of 9:10-dimethyl-1:2-benzanthracene. The latter proved very effective for rat skin, giving rise to 14 tumours (11 of these were malignant) in 20 rats when applied once a week as a 0.5 per cent solution in benzene during 45 weeks.
By comparison with 9:10-dimethyl-1:2-benzanthracene (potency Grade VI, when graded according to the system of Berenblum (1945)), 8-methoxy-3:4-benzpyrene showed towards the skin of rats the potency Grade V, only a little weaker than the former. However, both compounds were equally effective in their sarcomatogenic action (Grade VII).
8-Methoxy-3:4-benzpyrene proved rather irritating when injected subcutaneously into mice, resembling in this repect 9:10-dimethyl-1:2-benzanthracene and related compounds (Bachmann, Kennaway and Kennaway, 1938) .
The tissues sloughed off 4 to 5 weeks after the injection, and most of the compound was discharged. Thus in mice the results of subcutaneous injection are probably not truly representative, and more reliable data could be obtained with a lower dosage. In the two experiments with this compound using 2 mg./0.2 ml. and 0.5 mg./0.1 ml. per mouse respectively, tumours appeared earlier following the lower dosage, but even the latter was too irritating and many animals remained with scars, tumour-free, for many months.
The outstanding carcinogenic activity of 8-methoxy-3:4-benzpyrene is not shared by the other two isomers so far tested, namely, 4'-and 5-methoxy-3:4-benzpyrenes (Cook and de Worms, 1937; Shear, 1939; Berenblum and Schoental, 1944) , nor by 4'-methoxy-9:10-dimethyl-1:2:benzanthracene, considered to be the methylation product of the phenolic rat metabolite of the highly carcinogenic 9:10-dimethyl-1 :2-benzanthracene (Dickens, 1946) . With the exception of 5-methoxy-3:4-benzpyrene which produced sarcomata in 2 out of 10 mice, these were inactive.
Carcinogenic activity seems more general among the methyl derivatives of 3:4-benzpyrene. Including the active 8-methyl compound for which results are recorded in Table III , data are now available for eight of the twelve theoretically possible monomethylbenzpyrenes (Schiirch and Winterstein, 1935; Shear, 1939; Shear and Leiter, 1940; Dunlap and Warren, 1941; Dunlap and Warren, quoted by Fieser and Heymann, 1941; Dunlap, quoted by Jones, 1942) . Of these only two have proved inactive (the 2'-and 3'-methyl compounds). It is evident from a survey of the data that, although 8-methyl-and 8-methoxy-3:4-benzpyrene are both strongly carcinogenic, no general parallelism exists in the carcinogenic response of other methyl and methoxy derivatives of benzpyrene.
For instance, both 4'-methyl-and 5-methyl-3:4-benzpyrene gave tumours in a very high proportion of the treated mice although, as stated above, the 4'-methoxy compound was inactive and the 5-methoxy compound feebly active. A similar lack of parallelism is shown by methyl-and methoxy-derivatives of other polycyclic aromatic hydrocarbons (compare 9:10-dimethyl-and 9:10-dimethoxy-1:2-benzanthracene; although the former is a very potent carcinogen, the latter failed to produce tumours in 15 months after subcutaneous injection of 2 mg. into each of 10 mice (Berenblum and Schoental, 1944) ). The fact that 8-methyl-3:4-benzpyrene is an effective carcinogen discounts the suggestion of Greenwood (1951) , who explained the inactivity of 4'-methyl-1:2-benzanthracene by postulating that a methyl substituent at the metabolically attacked position may interfere with the metabolic process and thus destroy the potential activity of the compound. (a) 8-Hydroxy-3:4-benzpyrene (a phenolic metabolite of 3:4-benzpyrene) produced tumours after more than 69 weeks of application to the skin of mice, but none by the subcutaneous route. Thus its carcinogenic activity is rather feeble.
(b) 8-Methoxy-3:4-benzpyrene produced sarcomata readily in mice and rats when injected subcutaneously. It also produced tumours not only in all the mice but also in the skin of all the rats to which it was applied. The high malignancy of the skin tumours in the rats was indicated by the presence of secondary keratinizing carcinomata in the lymphoid tissues, and by the growth of transplants in weanling rats. Thus, this methyl ether of a metabolite of 3:4-benzpyrene ranks among the most potent carcinogens so far known for mice and rats.
(c) 8-Methyl-3:4-benzpyrene tested by the subcutaneous route in mice produced in all the animals tested highly malignant haemorrhagic tumours invading the adjacent muscle and other tissues. The potency of this methylderivative is at least equal to that of 3:4-benzpyrene itself; tumours developed very quickly, 50 per cent of the animals having tumours in 15 weeks.
